23andMe Files for Bankruptcy, CEO Resigns
Tap title to read story
23andMe, the genetic testing company, filed for Chapter 11 bankruptcy and is seeking to sell its assets. CEO Anne Wojcicki resigned, following a rejected acquisition proposal and months of turmoil including layoffs and the discontinuation of its therapeutics division. The company, struggling with profitability since its 2021 IPO, hopes a court-supervised sale will maximize value and resolve liabilities, while ensuring customer data protection. 23andMe has secured $35 million in financing to continue operations.
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.